Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer

TMI is a simple, cost-effective prognostic tool for mCRC, with high TMI associated with poorer survival outcomes.

Authors

Sahnura Uzuntas
Bilgin Demir (ORCID: https://orcid.org/0000-0003-4380-9419)
Onur Yazdan Balçık (ORCID: https://orcid.org/0000-0002-3386-2075)
Yusuf İlhan (ORCID: https://orcid.org/0000-0002-2875-6876)
Mehmet Nuri Başer (ORCID: https://orcid.org/0000-0003-1809-5581)
Yakup Ergün (ORCID: https://orcid.org/0000-0003-4784-6743)
İbrahim Karadağ (ORCID: https://orcid.org/0000-0002-2356-6790)
Tuğrul Burak Genç (ORCID: https://orcid.org/0000-0002-1302-359X)
Arif Hakan Önder (ORCID: https://orcid.org/0000-0002-0121-5228)
İsmail Beypınar (ORCID: https://orcid.org/0000-0002-0853-4096)
Mehmet Fatih Ozbay (ORCID: https://orcid.org/0000-0002-3883-4364)
Halil Göksel Güzel (ORCID: https://orcid.org/0000-0001-8310-1752)
Banu Öztürk (ORCID: https://orcid.org/0000-0003-0290-8787)
Orhan Kürşat Poyrazoğlu (ORCID: https://orcid.org/0000-0003-4841-8644)